The FDA has often approved new drug applications for opioids based on trials of inadequate length that included only patients who could tolerate the drugs, according to researchers. “Despite the scope of America's ongoing opioid epidemic, little is known ...
from Google Alert - health https://ift.tt/2EH8muN
via IFTTT
0 comments:
Post a Comment